Rewiring of cortical glucose metabolism fuels human brain cancer growth
Scott, A. J.; Mittal, A.; Meghdadi, B.; Palavalasa, S.; Achreja, A.; O'Brien, A.; Kothari, A. U.; Zhou, W.; Xu, J.; Lin, A.; Wilder-Romans, K.; Edwards, D. M.; Wu, Z.; Feng, J.; Andren, A. C.; Zhang, L.; Tarnal, V.; Redic, K. A.; Qi, N.; Fischer, J.; Yang, E.; Regan, M. S.; Stopko, S. A.; Baquer, G.; Lawrence, T. S.; Venneti, S.; Agar, N. Y. R.; Lyssiotis, C. A.; Al-Holou, W. N.; Nagrath, D.; Wahl, D. R.
Show abstract
The brain avidly consumes glucose to fuel neurophysiology. Cancers of the brain, such as glioblastoma (GBM), lose aspects of normal biology and gain the ability to proliferate and invade healthy tissue. How brain cancers rewire glucose utilization to fuel these processes is poorly understood. Here we perform infusions of 13C-labeled glucose into patients and mice with brain cancer to define the metabolic fates of glucose-derived carbon in tumor and cortex. By combining these measurements with quantitative metabolic flux analysis, we find that human cortex funnels glucose-derived carbons towards physiologic processes including TCA cycle oxidation and neurotransmitter synthesis. In contrast, brain cancers downregulate these physiologic processes, scavenge alternative carbon sources from the environment, and instead use glucose-derived carbons to produce molecules needed for proliferation and invasion. Targeting this metabolic rewiring in mice through dietary modulation selectively alters GBM metabolism and slows tumor growth. SignificanceThis study is the first to directly measure biosynthetic flux in both glioma and cortical tissue in human brain cancer patients. Brain tumors rewire glucose carbon utilization away from oxidation and neurotransmitter production towards biosynthesis to fuel growth. Blocking these metabolic adaptations with dietary interventions slows brain cancer growth with minimal effects on cortical metabolism.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Purine metabolism regulates DNA repair and therapy resistance in glioblastoma 95%
- Imaging the master regulator of the antioxidant response in non-small cell lung cancer with positron emission tomography 94%
- Drug and single-cell gene expression integration identifies sensitive and resistant glioblastoma cell populations 94%
Similar papers in this journal
Similar papers in this journal
Similar papers in this journal
- The expression profile and tumorigenic mechanisms of CD97 (ADGRE5) in glioblastoma render it a targetable vulnerability 95%
- Single-nucleus and spatial landscape of the sub-ventricular zone in human glioblastoma 94%
- NRCAM variant defined by microexon skipping is a targetable cell surface proteoform in high-grade gliomas 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.